You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CD155

Showing 1 - 25 of 741
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)

Recruiting
  • Cancer
  • +4 more
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 24, 2023

CD155 in Bladder Cancer

Recruiting
  • Bladder Cancer
  • Adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 3, 2020

Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Urothelial Carcinoma, Metastatic Renal Cell Carcinoma Trial

Completed
  • Metastatic Castration-resistant Prostate Cancer (mCRPC)
  • +2 more
  • Isovue-M 200
  • Durham, North Carolina
    Duke University Medical Center
Apr 1, 2022

miR-155 Expression in Episodic and Chronic Migraine

Recruiting
  • Migraine
  • +3 more
    • Pavia, Italy
      IRCCS Mondino Foundation
    Jun 7, 2023

    Parkinson's Disease (Disorder) Trial in Worldwide (IR CD-LD, IPX203 ER CD-LD, IPX203 )

    Completed
    • Parkinson's Disease (Disorder)
    • IR CD-LD
    • +3 more
    • Phoenix, Arizona
    • +107 more
    Jul 22, 2021

    Advanced Malignant Tumors Trial (AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion)

    Not yet recruiting
    • Advanced Malignant Tumors
    • AK127 Q3W IV infusion ,AK104 10mg/kg Q3W IV infusion
    • (no location specified)
    May 11, 2023

    Diabetes, Type 2 Trial in Salamanca (Vibration exercise)

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Vibration exercise
    • Salamanca, Spain
      University of Salamanca
    Jul 21, 2023

    Mycosis Fungoides Trial in Leiden (Chlormethine)

    Recruiting
    • Mycosis Fungoides
    • Leiden, Netherlands
      Centre for Human Drug Research
    Mar 29, 2022

    Response in Patients Treated by Immunotherapy for Advanced

    Not yet recruiting
    • Hepatocellular Carcinoma
    • patients with hepatocellular carcinoma
    • (no location specified)
    Jan 28, 2022

    Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

    Recruiting
    • Endometrial Neoplasms
    • +3 more
    • COM701 in combination with BMS-986207 and nivolumab.
    • Chicago, Illinois
    • +8 more
    Aug 8, 2022

    Lumbar Disc Herniation Trial in Bani Suwayf (transforaminal epidural injection., micro RNA-155 serum level)

    Recruiting
    • Lumbar Disc Herniation
    • transforaminal epidural injection.
    • micro RNA-155 serum level
    • Banī Suwayf, Beni-Suef, Egypt
      Mona Hussein
    Nov 19, 2022

    Hepatitis B, Chronic Trial in Worldwide (GSK3228836, GSK3528869A, Control)

    Recruiting
    • Hepatitis B, Chronic
    • Edegem, Belgium
    • +47 more
    Jan 24, 2023

    High-Frequency Ventilation Trial in Hat-Yai (HFOV-sigh)

    Enrolling by invitation
    • High-Frequency Ventilation
    • HFOV-sigh
    • Hat-Yai, Songkhla, Thailand
      Songklanagarind Hospital, Prince of Songkla University
    Jan 11, 2023

    Advanced Solid Tumors Trial in Australia, Korea, Republic of (FPT155, pembrolizumab)

    Completed
    • Advanced Solid Tumors
    • FPT155
    • pembrolizumab
    • Camperdown, New South Wales, Australia
    • +11 more
    Jan 6, 2022

    HIV, Pregnancy Malaria, Sexually Transmitted Infection Trial in Birmingham (Azithromycin/TMPS, Placebo/TMPS)

    Completed
    Has Results
    • HIV
    • +2 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jul 21, 2022

    Hepatitis B, Chronic Trial in Worldwide (ChAd155-hIi-HBV low dose formulation, ChAd155-hIi-HBV high dose formulation,

    Recruiting
    • Hepatitis B, Chronic
    • ChAd155-hIi-HBV low dose formulation
    • +6 more
    • Antwerpen, Belgium
    • +35 more
    Jan 28, 2022

    Crohn's Disease Trial (Vedolizumab IV, Placebo)

    Not yet recruiting
    • Crohn's Disease
    • Vedolizumab IV
    • Placebo
    • (no location specified)
    Apr 20, 2023

    Crohn's Disease Trial in Worldwide (ABBV-154, Placebo)

    Recruiting
    • Crohn's Disease
    • Dothan, Alabama
    • +185 more
    Jan 27, 2023

    Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

    Recruiting
    • Cancer
    • +4 more
    • INKmune
    • Athens, Attiki, Greece
    • +2 more
    Jul 3, 2023

    Progressive Multifocal Leukoencephalopathy Trial run by the NINDS (NT-I7)

    Recruiting
    • Progressive Multifocal Leukoencephalopathy
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 2, 2022

    Regional Nodal Basins and Gene Expression Profiling in Primary

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma of the Head and Neck
    • Ultrasound
    • 40-GEP
    • (no location specified)
    Jul 12, 2023

    Outcome of Very Preterm Infants With Glucose Level Disturbances

    Enrolling by invitation
    • Cerebral Palsy Infantile
    • 10% dextrose
    • bolus of dextrose, reducing the glucose infusion, insulin
    • Rijeka, Croatia
      University Hospital Center Rijeka
    Jun 22, 2022

    Celiac Disease Trial in United States (Continuous telemedicine monitoring plus gluten detection technology, Continuous

    Not yet recruiting
    • Celiac Disease
    • Continuous telemedicine monitoring plus gluten detection technology
    • Continuous telemedicine monitoring
    • Chicago, Illinois
    • +3 more
    Sep 22, 2023

    Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

    Recruiting
    • Nonalcoholic Steatohepatitis
    • Taipei, Taiwan
    • +1 more
    Feb 8, 2023

    Cardiogenic Shock Trial in United States (Vasopressor, Inotrope, Acute Mechanical Circulatory Support Devices)

    Recruiting
    • Cardiogenic Shock
    • Weston, Florida
    • +15 more
    Jan 17, 2023